Literature DB >> 29948073

Real-time MR-guided brain biopsy using 1.0-T open MRI scanner.

Xiangmeng He1, Ming Liu1, Chao Liu2, Jing Fang3, Yujun Xu1, Ligang Wang4, Jianfeng Xiang5, Roberto Blanco Sequeiros6, Chengli Li7.   

Abstract

OBJECTIVES: To evaluate the safety, feasibility and diagnostic performance of real-time MR-guided brain biopsy using a 1.0-T open MRI scanner.
METHODS: Medical records of 86 consecutive participants who underwent brain biopsy under the guidance of a 1.0-T open MRI scanner with real-time and MR fluoroscopy techniques were evaluated retrospectively. All procedures were performed under local anaesthesia and intravenous conscious sedation. Diagnostic yield, diagnostic accuracy, complication rate and procedure duration were assessed. The lesions were divided into two groups according to maximum diameters: ≤ 1.5 cm (n = 16) and > 1.5 cm (n = 70). The two groups were compared using Fisher's exact test.
RESULTS: Diagnostic yield and diagnostic accuracy were 95.3% and 94.2%, respectively. The diagnostic yield of lesions ≤ 1.5 cm and > 1.5 cm were 93.8% and 95.7%, respectively. There was no significant difference in diagnostic yield between the two groups (p > 0.05). Mean procedure duration was 41 ± 5 min (range 33-49 min). All biopsy needles were placed with one pass. Complication rate was 3.5% (3/86). Minor complications included three cases of a small amount of haemorrhage. No serious complications were observed.
CONCLUSIONS: Real-time MR-guided brain biopsy using a 1.0-T open MRI scanner is a safe, feasible and accurate diagnostic technique for pathological diagnosis of brain lesions. The procedure duration is shortened and biopsy work flow is simplified. It could be considered as an alternative for brain biopsy. KEY POINTS: • Real-time MRI-guided brain biopsy using a 1.0-T open MRI scanner is safe, feasible and accurate. • No serious complications occurred in real-time MRI-guided brain biopsy. • Procedure duration is shortened and biopsy work flow is simplified.

Entities:  

Keywords:  Biopsy; Fluoroscopy; Interventional radiology; Magnetic resonance imaging; Technology

Mesh:

Year:  2018        PMID: 29948073     DOI: 10.1007/s00330-018-5531-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  30 in total

1.  Stereotactic biopsies guided by an optical navigation system: technique and clinical experience.

Authors:  P Grunert; J Espinosa; C Busert; M Günthner; R Filippi; S Farag; N Hopf
Journal:  Minim Invasive Neurosurg       Date:  2002-03

2.  Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique.

Authors:  Graeme F Woodworth; Matthew J McGirt; Amer Samdani; Ira Garonzik; Alessandro Olivi; Jon D Weingart
Journal:  J Neurosurg       Date:  2006-02       Impact factor: 5.115

3.  Comparing the risks of frameless stereotactic biopsy in eloquent and noneloquent regions of the brain: a retrospective review of 284 cases.

Authors:  Ellen L Air; James L Leach; Ronald E Warnick; Christopher M McPherson
Journal:  J Neurosurg       Date:  2009-10       Impact factor: 5.115

Review 4.  Brain biopsy using high-field strength interventional magnetic resonance imaging.

Authors:  W A Hall; A J Martin; H Liu; E S Nussbaum; R E Maxwell; C L Truwit
Journal:  Neurosurgery       Date:  1999-04       Impact factor: 4.654

5.  Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases.

Authors:  Matthew J McGirt; Graeme F Woodworth; Alex L Coon; James M Frazier; Eric Amundson; Ira Garonzik; Alessandro Olivi; Jon D Weingart
Journal:  J Neurosurg       Date:  2005-05       Impact factor: 5.115

6.  Clinical validation of true frameless stereotactic biopsy: analysis of the first 125 consecutive cases.

Authors:  T S Paleologos; N L Dorward; J P Wadley; D G Thomas
Journal:  Neurosurgery       Date:  2001-10       Impact factor: 4.654

7.  Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen.

Authors:  Graeme Woodworth; Matthew J McGirt; Amer Samdani; Ira Garonzik; Alessandro Olivi; Jon D Weingart
Journal:  Neurol Res       Date:  2005-06       Impact factor: 2.448

8.  Frame-based stereotactic biopsy remains an important diagnostic tool with distinct advantages over frameless stereotactic biopsy.

Authors:  Justin S Smith; Alfredo Quiñones-Hinojosa; Nicholas M Barbaro; Michael W McDermott
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

9.  Safety and efficacy of frameless and frame-based intracranial biopsy techniques.

Authors:  R Dammers; I K Haitsma; J W Schouten; J M Kros; C J J Avezaat; A J P E Vincent
Journal:  Acta Neurochir (Wien)       Date:  2008-01-03       Impact factor: 2.216

Review 10.  Frame-based stereotaxy in a frameless era: current capabilities, relative role, and the positive- and negative predictive values of blood through the needle.

Authors:  Christopher M Owen; Mark E Linskey
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

View more
  2 in total

1.  CT-MR Image Fusion for Post-Implant Dosimetry Analysis in Brain Tumor Seed Implantation- a Preliminary Study.

Authors:  Menglong Zhang; Cunkun Chu; Liyin Huang; Bijuan Hu
Journal:  Dis Markers       Date:  2022-05-17       Impact factor: 3.464

2.  A novel three-dimensional template combined with MR-guided 125I brachytherapy for recurrent glioblastoma.

Authors:  Xiangmeng He; Ming Liu; Menglong Zhang; Roberto Blanco Sequeiros; Yujun Xu; Ligang Wang; Chao Liu; Qingwen Wang; Kai Zhang; Chengli Li
Journal:  Radiat Oncol       Date:  2020-06-08       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.